Patient-derived malignant pleural mesothelioma cell cultures: A tool to advance biomarker-driven treatments

We designed and conducted a translational study to assess the feasibility of patient-derived cell cultures to serve as an ex vivo MPM model that could be employed to investigate the feasibility of biomarker-driven personalised treatment.